Related Experiment Video
Updated: Aug 16, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
Aldo Moggio1, Heribert Schunkert1,2, Thorsten Kessler1,2
1Department of Cardiology, German Heart Center Munich, Technical University Munich, 80636 Munich, Germany.
Insights
Myocardial infarction triggers inflammation, depleting blood leukocytes. This review examines the "leukocyte supply chain" from bone marrow to heart post-infarction.
Area of Science:
- Cardiovascular Science
- Immunology
- Hematology
Background:
- Myocardial infarction (MI) causes heart tissue damage due to insufficient blood flow.
- This ischemic injury initiates a significant inflammatory response, recruiting large numbers of leukocytes.
- The depletion of circulating leukocytes necessitates rapid replenishment.
Purpose of the Study:
- To review the "leukocyte supply chain" in the context of myocardial infarction.
- To evaluate myeloid cell compartments (bone marrow, spleen, blood, heart) in steady state and post-MI.
- To highlight the role of extracellular factors and chemokines in myeloid cell regulation during MI inflammation.
Main Methods:
- Review of existing literature on leukocyte kinetics and inflammatory responses post-MI.
- Analysis of myeloid cell populations in different anatomical compartments.
- Examination of signaling molecules regulating myeloid cell behavior.
Main Results:
- MI leads to rapid depletion of blood leukocytes, requiring mobilization from supply organs.
- Myeloid cell generation, release, and trafficking are dynamically regulated after cardiac injury.
- Specific chemokines and danger signals orchestrate the inflammatory cell response.
Conclusions:
- Understanding the leukocyte supply chain is crucial for managing MI-induced inflammation.
- Targeting myeloid cell kinetics may offer novel therapeutic strategies for heart attack recovery.
- The interplay between local injury and systemic myeloid cell responses is complex and vital.
Abstract:
Myocardial infarction (MI), a major contributor to worldwide morbidity and mortality, is caused by a lack of blood flow to the heart. Affected heart tissue becomes ischemic due to deficiency of blood perfusion and oxygen delivery. In case sufficient blood flow cannot be timely restored, cardiac injury with necrosis occurs. The ischemic/necrotic area induces a systemic inflammatory response and hundreds of thousands of leukocytes are recruited from the blood to the injured heart. The blood pool of leukocytes is rapidly depleted and urgent re-supply of these cells is needed. Myeloid cells are generated in the bone marrow (BM) and spleen, released into the blood, travel to sites of need, extravasate and accumulate inside tissues to accomplish various functions. In this review we focus on the "leukocyte supply chain" and will separately evaluate different myeloid cell compartments (BM, spleen, blood, heart) in steady state and after MI. Moreover, we highlight the local and systemic kinetics of extracellular factors, chemokines and danger signals involved in the regulation of production/generation, release, transportation, uptake, and activation of myeloid cells during the inflammatory phase of MI.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management

